Weinstein Cardiovascular Development and Regeneration Conference

韦恩斯坦心血管发育与再生会议

• 批准号: 10683505
• 负责人: DEBORAH YELON
• 金额: $ 3万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-03-15 至 2024-02-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10683505
• 关键词: Adult; Affect; American Heart Association; Award; California; Cardiac; Cardiovascular Diseases; Cardiovascular system; Categories; Childhood; Clinical; Collaborations; Committee Members; Communities; Comprehension; Congenital Abnormality; Data; Development; Developmental Biology; Disabled Persons; Embryology; Engineering; Environment; Etiology; Europe; Event; Faculty; Fees; Financial Support; Funding; Gene Expression; Goals; Growth; Health; Human Genetics; Individual; Infant Mortality; Institution; Live Birth; Medical; Mentors; Mission; Molecular; Myocardial dysfunction; National Heart, Lung, and Blood Institute; Natural regeneration; Oral; Parents; Pathology; Patients; Postdoctoral Fellow; Publishing; Regenerative Medicine; Regulation; Reporting; Request for Applications; Request for Proposals; Research; Research Personnel; Scientist; Seasons; Series; Societies; Structural Congenital Anomalies; Talents; Therapeutic; Tissue Engineering; Training; Transcriptional Regulation; Travel; Underrepresented Populations; Universities; Woman; Work; cardiogenesis; career; collaborative environment; congenital heart disorder; cost; early-career faculty; gene function; graduate student; improved; innovation; meetings; next generation; novel; prevent; secondary outcome; stillbirth; symposium; symptom treatment; targeted treatment

PROJECT SUMMARY This proposal requests support for the 2023 Weinstein Cardiovascular Development and Regeneration Conference, which will be held in San Diego, California. The Weinstein Cardiovascular Development and Regeneration Conference was founded to create an open forum for investigators studying the etiology, pathology, and eventual treatment of congenital heart diseases (CHDs). This tradition initiated with a series of annual meetings that brought together investigators who were funded by three separate NIH RFAs on Cardiac Development; these RFAs, the first of which was issued in 1984, were sponsored by Dr. Constance Weinstein and her colleagues at the NHLBI. Since its origins, this conference has been the premier opportunity for researchers in the field of cardiovascular developmental biology to meet and share their data and ideas. During the 3-day meeting, basic scientists, clinicians, engineers, and geneticists come together to interact and discuss a multitude of cardiovascular developmental mechanisms and their impact on CHDs, as well as the secondary outcomes that result in adult cardiac dysfunction. This conference is unique for several reasons. First, it is a freestanding meeting that is entirely organized by active researchers within the cardiovascular developmental biology community who are unaffiliated with any society or parent organization. Second, with the exception of the keynote speakers, all oral platform presentations are chosen from abstracts submitted by early career faculty, postdoctoral fellows, and graduate students. This approach insures that only cutting-edge data are shown and avoids repetitive presentations by established investigators selected solely by reputation. Third, this conference is consistently attended by a substantial number of senior investigators in the cardiovascular developmental biology field, even though they are not delivering oral presentations and are required to pay for their own registration and travel expenses. Fourth, the conference community maintains a welcoming and collaborative atmosphere that encourages sharing of innovative and unpublished data. As in prior iterations of this conference, the objectives of the 2023 Weinstein Cardiovascular Development and Regeneration Conference are to promote a collegial environment for dissemination and discussion of innovative and unpublished scientific findings, to encourage interactions and collaborations among colleagues in the field, and to enhance the professional development of a diverse array of early career faculty, postdoctoral fellows, and graduate students by providing a platform for the presentation of their data and an opportunity to network and interact with established cardiovascular developmental biologists. In this application, financial support is requested to subsidize registration fees for trainees in order to encourage robust attendance of early career researchers, to provide financial assistance in the form of travel awards for selected trainees, with a particular focus on supporting attendance of women, underrepresented groups, and individuals with disabilities, and to support general conference costs.

项目摘要 该建议要求支持2023年温斯坦心血管发展和再生 会议将在加利福尼亚州圣地亚哥举行。温斯坦心血管发育和 建立了再生会议是为了创建一个开放论坛，用于研究病因的研究人员， 病理学和先天性心脏病（CHD）的最终治疗。这一传统发起了一系列 年度会议汇集了由三个独立的NIH RFA资助的调查人员 发展;这些RFA是1984年发行的第一个RFA，是由Constance Weinstein博士赞助的 她在NHLBI的同事。自从其起源以来，这次会议一直是首要的机会 心血管发育生物学领域的研究人员满足和分享他们的数据和想法。期间 为期三天的会议，基础科学家，临床医生，工程师和遗传学家聚集在一起进行互动和讨论 多种心血管发育机制及其对CHD的影响以及次要的 导致成人心脏功能障碍的结果。这次会议是独一无二的，原因有几个。首先，这是一个 自由主义会议完全由心血管发展中的活跃研究人员组织 与任何社会或家长组织无关的生物学社区。第二，除了 主题演讲者，所有口头平台演示文稿都是从早期职业提交的摘要中选择的 教师，博士后研究员和研究生。这种方法确保只有最先进的数据是 显示并避免了仅由声誉选择的既定研究人员的重复演示。第三，这个 大量高级调查员在心血管中始终参加会议 发展生物学领域，即使他们没有提供口头介绍，也必须支付 他们自己的注册和旅行费用。第四，会议社区维持一个热情和 协作氛围鼓励共享创新和未发表的数据。就像以前的迭代 这次会议是2023年温斯坦心血管发展和再生的目标 会议旨在促进一个大学环境，以进行创新和讨论 未发表的科学发现，以鼓励该领域的同事之间进行互动和合作，并 为了增强各种各样的早期职业教师，博士后研究员和 研究生通过提供一个平台来显示其数据，并有机会网络和网络 与已建立的心血管发育生物学家互动。在此应用程序中，财政支持是 要求为学员补贴注册费，以鼓励早期职业的出勤 研究人员，以选定的学员的旅行奖的形式提供经济援助，并具有特定的 专注于支持妇女，人为不足的群体和残疾人的出勤率，以及 支持大会费用。